Literature DB >> 26589911

UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?

Sujata Bhoi1, Panagiotis Baliakas1, Diego Cortese1, Mattias Mattsson2, Marie Engvall1, Karin E Smedby3, Gunnar Juliusson4, Lesley-Ann Sutton1, Larry Mansouri5.   

Abstract

Entities:  

Keywords:  CLL; UGT2B17; prognostic markers

Mesh：

Substances：

Year:  2015        PMID： 26589911      PMCID： PMC4938332          DOI： 10.3324/haematol.2015.136440

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia.

Authors:  U Thunberg; A Johnson; G Roos; I Thörn; G Tobin; J Sällström; C Sundström; R Rosenquist
Journal:  Blood       Date:  2001-03-15       Impact factor: 22.113

Review 2.  RNA-based markers as prognostic factors in chronic lymphocytic leukemia.

Authors:  Marie Sevov; Richard Rosenquist; Larry Mansouri
Journal:  Expert Rev Hematol       Date:  2012-02       Impact factor: 2.929

3.  LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia.

Authors:  Mohd Arifin Kaderi; Meena Kanduri; Anne Mette Buhl; Marie Sevov; Nicola Cahill; Rebeqa Gunnarsson; Mattias Jansson; Karin Ekström Smedby; Henrik Hjalgrim; Jesper Jurlander; Gunnar Juliusson; Larry Mansouri; Richard Rosenquist
Journal:  Haematologica       Date:  2011-04-20       Impact factor: 9.941

4.  Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia.

Authors:  Davide Rossi; Silvia Rasi; Valeria Spina; Alessio Bruscaggin; Sara Monti; Carmela Ciardullo; Clara Deambrogi; Hossein Khiabanian; Roberto Serra; Francesco Bertoni; Francesco Forconi; Luca Laurenti; Roberto Marasca; Michele Dal-Bo; Francesca Maria Rossi; Pietro Bulian; Josep Nomdedeu; Giovanni Del Poeta; Valter Gattei; Laura Pasqualucci; Raul Rabadan; Robin Foà; Riccardo Dalla-Favera; Gianluca Gaidano
Journal:  Blood       Date:  2012-12-13       Impact factor: 22.113

5.  NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia.

Authors:  L Mansouri; N Cahill; R Gunnarsson; K E Smedby; E Tjönnfjord; H Hjalgrim; G Juliusson; C Geisler; R Rosenquist
Journal:  Leukemia       Date:  2012-11-06       Impact factor: 11.528

6.  Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia.

Authors:  Michaela Gruber; Judith Bellemare; Gregor Hoermann; Andreas Gleiss; Edit Porpaczy; Martin Bilban; Trang Le; Sonja Zehetmayer; Christine Mannhalter; Alexander Gaiger; Medhat Shehata; Karin Fleiss; Cathrin Skrabs; Éric Lévesque; Katrina Vanura; Chantal Guillemette; Ulrich Jaeger
Journal:  Blood       Date:  2012-11-20       Impact factor: 22.113

7.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

Authors:  R N Damle; T Wasil; F Fais; F Ghiotto; A Valetto; S L Allen; A Buchbinder; D Budman; K Dittmar; J Kolitz; S M Lichtman; P Schulman; V P Vinciguerra; K R Rai; M Ferrarini; N Chiorazzi
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

8.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

Authors:  T J Hamblin; Z Davis; A Gardiner; D G Oscier; F K Stevenson
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

9.  Function of UDP-glucuronosyltransferase 2B17 (UGT2B17) is involved in endometrial cancer.

Authors:  Hiroshi Hirata; Yuji Hinoda; Mohd S Zaman; Yi Chen; Koji Ueno; Shahana Majid; Christina Tripsas; Mary Rubin; Lee-May Chen; Rajvir Dahiya
Journal:  Carcinogenesis       Date:  2010-06-16       Impact factor: 4.944

10.  Recurrent mutations refine prognosis in chronic lymphocytic leukemia.

Authors:  P Baliakas; A Hadzidimitriou; L-A Sutton; D Rossi; E Minga; N Villamor; M Larrayoz; J Kminkova; A Agathangelidis; Z Davis; E Tausch; E Stalika; B Kantorova; L Mansouri; L Scarfò; D Cortese; V Navrkalova; M J J Rose-Zerilli; K E Smedby; G Juliusson; A Anagnostopoulos; A M Makris; A Navarro; J Delgado; D Oscier; C Belessi; S Stilgenbauer; P Ghia; S Pospisilova; G Gaidano; E Campo; J C Strefford; K Stamatopoulos; R Rosenquist
Journal:  Leukemia       Date:  2014-06-19       Impact factor: 11.528
View more
  6 in total

1.  Sex-dependent association of circulating sex steroids and pituitary hormones with treatment-free survival in chronic lymphocytic leukemia patients.

Authors:  Eric P Allain; Karin Venzl; Patrick Caron; Véronique Turcotte; David Simonyan; Michaela Gruber; Trang Le; Eric Lévesque; Chantal Guillemette; Katrina Vanura
Journal:  Ann Hematol       Date:  2018-05-21       Impact factor: 3.673

2.  Role of long non-coding RNAs in disease progression of early stage unmutated chronic lymphocytic leukemia.

Authors:  Renee C Tschumper; Tait D Shanafelt; Neil E Kay; Diane F Jelinek
Journal:  Oncotarget       Date:  2019-01-01

3.  Hepatic Abundance and Activity of Androgen- and Drug-Metabolizing Enzyme UGT2B17 Are Associated with Genotype, Age, and Sex.

Authors:  Deepak Kumar Bhatt; Abdul Basit; Haeyoung Zhang; Andrea Gaedigk; Seung-Been Lee; Katrina G Claw; Aanchal Mehrotra; Amarjit Singh Chaudhry; Robin E Pearce; Roger Gaedigk; Ulrich Broeckel; Timothy A Thornton; Deborah A Nickerson; Erin G Schuetz; John K Amory; J Steven Leeder; Bhagwat Prasad
Journal:  Drug Metab Dispos       Date:  2018-03-30       Impact factor: 3.922

4.  UGT2B17 modifies drug response in chronic lymphocytic leukaemia.

Authors:  Eric P Allain; Michèle Rouleau; Katrina Vanura; Sophie Tremblay; Joanie Vaillancourt; Vincent Bat; Patrick Caron; Lyne Villeneuve; Adrien Labriet; Véronique Turcotte; Trang Le; Medhat Shehata; Susanne Schnabl; Dita Demirtas; Rainer Hubmann; Charles Joly-Beauparlant; Arnaud Droit; Ulrich Jäger; Philipp B Staber; Eric Lévesque; Chantal Guillemette
Journal:  Br J Cancer       Date:  2020-05-18       Impact factor: 7.640

5.  Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression.

Authors:  Eric Lévesque; Louis Lacombe; Chantal Guillemette; Adrien Labriet; Hélène Hovington; Éric P Allain; Luciana Melo-Garcia; Michèle Rouleau; Hervé Brisson; Véronique Turcotte; Patrick Caron; Lyne Villeneuve; Mickaël Leclercq; Arnaud Droit; Etienne Audet-Walsh; David Simonyan; Yves Fradet
Journal:  Br J Cancer       Date:  2020-02-12       Impact factor: 7.640

Review 6.  Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression.

Authors:  Eric P Allain; Michèle Rouleau; Eric Lévesque; Chantal Guillemette
Journal:  Br J Cancer       Date:  2020-02-12       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.